BUSINESS Adeia Inc., together with its subsidiaries, operates as a consumer and entertainment product/solutions licensing company worldwide. It licenses its innovations to companies in the entertainment industry under the Adeia brand. INVESTMENT RATING With future […]
Important negative changes in Oil States International Inc (NYSE: OIS) fundamentals have recently occurred: significant quarterly sales deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased […]
TransAlta’s common shares will need to reach $12 to achieve average annual stock market performance of 9.0% over the next 6 years. TransAlta’s stock price will need to reach $14 by 2029 to achieve upper […]
As reflected at the current price of $17, what future Riot Platforms operating performance is the market anticipating? To achieve average annual stock market performance of 9.0% over the next 6 years, Riot Platforms shares […]
BUSINESS Itron, Inc., a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and […]
Fresh Del Monte Produce Inc. (NYSE: FDP) has reported a loss for its fourth fiscal quarter (ending December 31) of $-2.22 versus $0.38 for the same period a year ago — a decline of -684%. […]
To achieve average annual stock market performance of 9.0% over the next 6 years, Fresh Del Monte Produce shares will need to reach $39. To achieve Upper quartile performance, Fresh Del Monte Produce’s stock price […]
BUSINESS Riot Blockchain, Inc., together with its subsidiaries, focuses on bitcoin mining operations in North America. It operates through Bitcoin Mining, Data Center Hosting, and Electrical Products and Engineering segments. As of December 31, 2021, […]
What is the market’s view of Banner’s future operating performance as reflected in the current price of $44? Banner’s common shares will need to reach $73 to achieve average annual stock market performance of 9.0% […]
For its fourth fiscal quarter (ending December 31), BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) has reported E.P.S. of $-0.31 compared to $-0.38 a year ago. This performance was $-0.08 short of the consensus estimate of $-0.23. […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research